Evidence E: Weeks 1–4 on tirzepatide (after the first fill, before the second)

Scope: the patient has completed the GLP-1 evaluation and the first fill has been transmitted/dispensed. This file covers day 0 through the week-4 dose-escalation decision: medication onboarding, care plan and next steps, scheduled medication check-ins, side-effect reporting and escalation, care-team messaging, General AI, notifications, refill timing for a 4-dose/28-day box, re-prescribing and PA renewal, month-1 billing, cancellation/pausing, adherence tracking, and weight/vitals capture.

Method: re-read the recovered first-party app (app/, lib/store/api/*, lib/*, components/*, contexts/, hooks/, packages/, types/) and the four internal-portal operation inventories; re-fetched public generalmedicine.co pages, public /api/external/* GETs, the Zepbound label, and LillyDirect pricing on 2026-10-19. Read-only GETs only; no account, form, checkout, or personal data.

Tag legend: [CODE path:line], [LIVE url, 2026-10-19], [DATA file → key], [DOC file §section], [PUBLIC url], [INFERENCE].

Recovery caveat that bounds this file. The recovered tree contains the account data layer and flow helpers but not the authenticated account page components (app/account/**, app/prescriptions/**, components/Prescriptions/* beyond criteriaNavigation.ts) and not types/interfaces/*. The check-in routes, API contracts, state machines and copy are therefore observed; the exact rendered page layout and the questionnaire text are not. The live account routes return 307 → /login (checked 2026-10-19), so no authenticated screen could be observed without creating an account. Every place this matters is marked [INFERENCE] or listed in §6.


0. The loop in one paragraph (what GM actually built)

GM does not run a subscription. It runs a visit-fee + dispense-fee + scheduled-criteria loop. A clinician signs an encounter, a Care::Plan is generated/curated and sent, the prescription becomes a PharmacyOrder that the patient must route to a pharmacy and pay for (or adjudicate), and the patient then self-injects weekly with no GM instrumentation. GM's only recurring levers are (a) the Updates/Next Steps feed, (b) the medication check-in (questionnaire + optional lab bundle) that is attached to the prescription's renewal criteria, (c) care-team messaging / SMS, and (d) the General AI copilot. The week-4 dose-escalation decision is a clinician action (changePhase / batchChangePatientMedicationPhases) that produces a new prescription for a new strength, which is a new pharmacy order and may be a new PA — not a modification of the existing fill.


1. Steps table

Clock definition. D0 is the first self-administered dose, not the first click. On a same-day cash path (LillyDirect/Amazon or retail pickup) D0 is usually the visit day; on an insured/PA path the fill can lag the visit by several business days. The click → visit → fill → first-dose offsets are not measured and are left Unknown; acquisition/intake timing belongs to evidence files A–D. Week numbers are days after the first dose.

step day/time patient sees / does GM system / screen / route data captured or emitted evidence
E1 D0, before first dose (same-day path) Sees the care plan land in the account: a plan with “next steps”, a “why this” rationale, and a prescription card. Care::Plan lifecycle; /account, /account/care-plans, /account/next-steps. GET /api/external/dashboard/show, GET /api/external/cares/{careId}, GET /api/external/next_steps/by_care/{careId}, GET /api/external/dashboard/next_step_cards. Plan copy: remainingMessage, caughtUpMessage, followUpAction: "Schedule visit", labsTitle: "Book {count} {noun}", bookLabsAction: "Book labs". care_id, plan_id, state (observed values include awaiting_curation, awaiting_external_work, awaiting_generation, awaiting_first_send, awaiting_curation_send, in_review, sent; the progression order is inferred from the names, not from an observed transition log), provider_message, patient_instructions, next-step type/state/lab_names/scheduled_at/lab_order_id/questionnaire_id/patient_rationale. [CODE lib/store/api/carePlanApi.ts:7-22,55-77]; [CODE lib/store/api/dashboardApi.ts:56-68]; [CODE lib/content/carePlan.ts:30-45]; [CODE components/CareActions/careActionSection.ts:37-91]; [DOC architecture.md §8.2]; [LIVE https://generalmedicine.co/p/lilly/weight-loss, 2026-10-19: “Prescriptions, lab orders, and referrals are sent right to your account”]
E1.1 D0, before first dose Opens the prescription card and is asked to choose a pharmacy and a payment mode. POST /api/external/prescriptions/{careActionPrescriptionId}/ensure_pharmacy_order creates the order, then GET /api/external/pharmacy_comparisons?medication_option_sku_id=…&latitude=…&longitude=…, POST /pharmacy_orders/{id}/select_pharmacy, then one of checkout, checkout_with_insurance, checkout_for_pharmacy_delegation. pharmacy_order_id, medication_option_sku_id, ncpdp_provider_id, arrive_rtpbi_inquiry_id, billing_type (cash/insurance/pharmacy_delegation/gm_card), cash_price, insurance_price, state. [CODE lib/api/endpoints.ts:236-239]; [CODE lib/store/api/pharmacyOrderApi.ts:26-118]; [DOC architecture.md §9.1]; [LIVE https://generalmedicine.co/api/external/pharmacy_comparisons?medication_option_sku_id=710641&latitude=37.7749&longitude=-122.4194, 2026-10-19]
E1.2 D0, before first dose Compares pharmacies; for a 2.5 mg Zepbound KwikPen sees LillyDirect and Amazon at $299 vs Walgreens/Costco/Safeway/Walmart at $496.12 and CVS at $508.09. Compare drawer / pharmacy order options. Featured manufacturer-direct pharmacies pinned above retail; 2 nearby retail : 1 online interleave; Amazon forced into the first online slot. NCPDP id, chain name, distance, total_price_cents, fulfillment owner (lilly_direct, amazon_pharmacy, cvs, walgreens, walmart, other_pharmacy). [LIVE https://generalmedicine.co/api/external/pharmacy_comparisons?medication_option_sku_id=710641&latitude=37.7749&longitude=-122.4194, 2026-10-19]; [CODE components/Refresh/SearchResults/searchPharmaciesUtils.ts:72-134]; [DOC architecture.md §9.1]
E1.3 D0−D3 (before first dose) Pays (cash pre-pay in-app, insurance copay at counter, or presents the GM savings card at the counter). Stripe payment for cash/gm_card; checkout_with_insurance for adjudication; checkout_for_pharmacy_delegation for the gm_card path. GET /pharmacy_orders/{id}/gm_card returns BIN/PCN/group/member. Last fill’s card is auto-selected via GET /prescription_orders/{orderId}/previous_fill_payment_method. payment_method_id, return_url, billing_type, gm_card {bin,pcn,group,member_id}, pharmacy_submission_state. [CODE lib/store/api/pharmacyOrderApi.ts:61-118]; [CODE lib/store/api/paymentServiceApi.ts:18-21]; [CODE lib/utilities.ts:949-979]; [LIVE https://generalmedicine.co/api/external/pharmacy_orders/{id}/gm_card is documented at openapi.yaml:1390-1420]; [DOC architecture.md §9.1]
E1.4 D0 (first dose) Gets a notification that the prescription was sent; picks up or receives the 4-dose box; takes the first injection. No GM “first dose” screen. Notification copy promise: “You’ll get a notification as soon as it’s sent.” Delivery: retail pickup, LillyDirect/Amazon delivery, or mail. Prescription sent event; pharmacy order state; no dose-taken event. [LIVE https://generalmedicine.co/faq, 2026-10-19: “You’ll get a notification as soon as it’s sent”]; [PUBLIC https://www.lilly.com/lillydirect/zepbound: “4 pens per monthly prescription”, delivery/pickup]; [INFERENCE] first-dose timing is patient-driven; no GM timestamp
E2 D0–D1 Learns to inject. Sources: the pharmacy label/SIG on the box, the manufacturer’s Instructions for Use, pharmacist counseling at pickup, any link/text the clinician put in patient_instructions, and the care team/AI if they ask. The app ships a formatInstructions normalizer for pharmacy SIGs, so the prescription detail is the likely renderer (the component itself was not recovered); care-plan patient_instructions auto-link any http(s) URL; messaging/AI are the fallback. No first-party injection-training module, video, or step-by-step guide exists in the recovered source. SIG text, patient_instructions (with autolinked URLs), presentation (KwikPen vs single-dose pen vs vial), needle requirement. [CODE lib/utilities.ts:620-660]; [CODE lib/autolinkText.ts:1-40]; [CODE components/ProductDetailPage/sharedSectionsData.ts:13-18]; [PUBLIC https://pi.lilly.com/us/zepbound-uspi.pdf §2.4: presentation-specific training required]; [PUBLIC https://www.lilly.com/lillydirect/zepbound: KwikPen “Pen needle purchase required”; single-dose pens include the needle]; [LIVE https://generalmedicine.co/ai, 2026-10-19: example prompt “I got prescribed a GLP-1, but I don’t know how to administer it.”]; negative grep: no inject/needle content module in the app
E3 D1–D27 Messages the care team or asks General AI about side effects, missed doses, food, labs, cost, or “what’s next”. Message Center /account/messages (Twilio Conversations) if the server-evaluated message-center flag is on; otherwise the “Text us” action opens SMS to the tenant number. General AI at /ai, /ai/chat, /ai/onboarding, /ai/health-records. Side-effect and adjustment visits are separate SKUs. Conversation/subject (visit, lab, pharmacy_order), message text, file-upload ids, response_expectation, AI messages, consent flags. [CODE lib/store/api/messageCenterApi.ts:18-108,168-270]; [CODE hooks/useContactSupport.ts:10,59-92]; [CODE contexts/AccountDashboardFeatureContext.tsx:9-28]; [CODE hooks/useGeneralAiStatus.tsx:166-220]; [LIVE https://generalmedicine.co/api/external/tenant_integrations/phone_number → {“phone_number”:“98528”}, 2026-10-19]; [LIVE https://generalmedicine.co/resources/using-a-glp-1-for-weight-loss, 2026-10-19: “message your care team … same-day support available during business hours”]
E4 D7, D14, D21 Takes doses 2, 3, 4. No GM screen, reminder, or confirmation. None. No dose scheduler, no push, no “mark as taken”, no adherence event. Nothing emitted. The only proxy is the eventual refill order and the check-in self-report. [PUBLIC https://pi.lilly.com/us/zepbound-uspi.pdf §2.1: once weekly]; [CODE negative: no service worker / Notification.requestPermission / pushManager / dose-log endpoint in recovered source or openapi.yaml]; [INFERENCE] the patient is unobserved between fills unless they initiate contact
E5 D21–D28 (window) Gets a refill reminder and/or sees a new check-in in Next Steps/Updates. Refill reminder promise; DashboardPrescription.earliest_fill_date, has_pending_criteria, criteria_deadline; CareJourneyGroup.available_at + locked gate time-based criteria; NextStepCard with deadline and assigned_by. earliest_fill_date, criteria_deadline, pending criteria count, next-step deadline, snooze/dismiss state. [CODE lib/store/api/dashboardApi.ts:27-43]; [CODE lib/store/api/careJourneyApi.ts:39-77]; [CODE lib/store/api/nextStepCardsApi.ts:16-45]; [LIVE https://generalmedicine.co/telehealth-informed-consent, 2026-10-19: “Prescription refill reminders (if applicable)”]; [LIVE https://generalmedicine.co/s/prescription-renewal/200007, 2026-10-19: “We’ll remind you when it’s time”]; [INFERENCE] exact offset (e.g. day 21 vs day 25) is server-side and not recovered
E6 D~28 Completes the medication check-in: a questionnaire, and labs if the prescription’s criteria require them (draw at Quest/Labcorp/BioReference or upload an external PDF). /account/medication-check-in (hub), /labs, /labs/upload, /progress, /complete; prescription-scoped /prescriptions/{id}/check-in, /questionnaire, /labs, /complete. APIs: GET /care_journey/next_steps, POST /care_journey/lab_bundle, POST /care_journey/complete_lab_upload, POST /care_journey/share_lab_upload_for_booking, POST /patient_medications/{id}/lab_bundle. summary.actionable_count, estimated_minutes, soonest_deadline; checklist item type (Lab/Questionnaire/Visit), status, locked, deadline, medication_names, lab_bundle, lab_sku_ids; questionnaire response id; lab_order_id; skus[]; submitted_at. [CODE lib/medicationCheckInLabFlow.ts:4-11,48-105]; [CODE lib/prescriptions/prescriptionCheckInFlow.ts:4-12,44-98]; [CODE lib/store/api/careJourneyApi.ts:39-77,99-180]; [CODE lib/store/api/prescriptionApi.ts:54-71]; [CODE lib/focusedFlow.ts:17-29]; [CODE lib/store/api/dashboardApi.ts:14: renewal-criteria questionnaires are excluded server-side from dashboard/show]; [LIVE https://generalmedicine.co/resources/using-a-glp-1-for-weight-loss, 2026-10-19: monthly check-ins while titrating]; [LIVE https://generalmedicine.co/p/lilly/weight-loss, 2026-10-19: “we’ll also reach out periodically … answer a few questions or get labs”]
E7 D~28 Waits for clinician review; may be asked to book a visit; is told to continue 2.5 mg, increase to 5 mg, lower the dose, or switch. Visitron review operations include createNextStepReview, generateNextStepReview (AI draft), updateNextStepReview, applyReview, rejectReview, confirmCarePlan, confirmNoChange (the exact call order is inferred). Dose change: changePhase, changePathway, batchChangePatientMedicationPhases. proposed_json → final_json, review decision, patient_rationale, new phase, new strength, visit request. [DATA osint/internal_portals_recon.json → visitron.rtk_endpoints]; [DOC architecture.md §8.2]; [PUBLIC https://pi.lilly.com/us/zepbound-uspi.pdf §2.1: after 4 weeks increase to 5 mg; 2.5 mg is not a maintenance dose]; [LIVE https://generalmedicine.co/s/weight-loss-follow-up/300550, 2026-10-19: “Discuss whether your current plan or dose is still the right fit”; “tradeoffs of increasing versus staying”]; [LIVE https://generalmedicine.co/api/external/product_detail_pages/710641, 2026-10-19: “increase every four weeks based on tolerance and response”]
E8 D28–D31 Gets a new prescription for the new strength (if escalated), re-selects the pharmacy, and pays the new price: 5 mg KwikPen $399 vs 2.5 mg $299 at LillyDirect/Amazon; retail stays ~$496–$508. New PharmacyOrder for the new medication_option_sku_id (new strength = new SKU), new select_pharmacy + checkout, possibly a new PA/RTPBI. New pharmacy_order_id, new medication_option_sku_id, new price, new PA requirement, new arrive_rtpbi_inquiry_id. [LIVE https://generalmedicine.co/api/external/medication_option_skus/710643/cash_price?zip_code=94107 → 39900, 2026-10-19]; [LIVE https://generalmedicine.co/api/external/pharmacy_comparisons?medication_option_sku_id=710643… → LillyDirect/Amazon $399, retail $496.12–$508.09, 2026-10-19]; [CODE lib/api/endpoints.ts:236-239]; [INFERENCE] new strength is a new NDC and commonly a new PA/step-therapy edit; no PA-submission endpoint was observed
E9 D28+ Orders the next 4-dose box; if on ≥7.5 mg at LillyDirect, must refill within 45 days to keep $449. Refill = direct pharmacy order when refills remain; renewal = NextStep::PrescriptionRenewal when none remain. prescription_renewal_destination chooses /prescriptions/renew/{nextStepId}, /prescriptions/renew, or the public 200007 page. due_date, on_next_step, open_to_renew, number_of_prescriptions, visit_options. [LIVE https://generalmedicine.co/api/external/product_detail_pages/710641 → default_days_supply 28, “28 days supply”, 2026-10-19]; [PUBLIC https://www.lilly.com/lillydirect/zepbound: “Month is defined as 28-days and 1 single-patient-use KwikPen”; 45-day refill window; late prices $499/$699]; [CODE lib/store/api/prescriptionRenewalApi.ts:5-22]; [CODE lib/store/api/prescriptionApi.ts:10-20]; [CODE hooks/usePrescriptionRenewalDestination.ts:22-30,54-66]; [LIVE https://generalmedicine.co/resources/medication-faqs, 2026-10-19: refill vs renewal; “most refill requests … same day”]
E10 D28+ Experiences the month-1 billing set: visit fee, medication cash/copay, optional labs, optional follow-up, possible cancellation fee. Stripe / pharmacy counter / lab checkout; GET /orders for receipts; GET /pharmacy_orders/{id}/invoice. billing_type, cash_price, insurance_price, clinical_fee_cents, payment_method_id, invoice_id. [LIVE https://generalmedicine.co/api/external/sku_options/300543, 2026-10-19]; [LIVE https://generalmedicine.co/api/external/lab_skus/503263, 2026-10-19]; [LIVE https://generalmedicine.co/cancellation-policy, 2026-10-19]; [CODE lib/store/api/patientOrdersApi.ts:7-13]; see §4
E11 Any time Cancels/reschedules a visit, cancels/switches a pharmacy order, declines a renewal, or simply stops refilling. There is no “pause subscription”. Visit cancellation by patient; POST /pharmacy_orders/{id}/cancel {pharmacy_change}; POST /next_step_prescription_renewals/{id}/decline {cancellation_reason}; completed_elsewhere; account closure by email to privacy@. Cancellation reason, can_cancel_pharmacy_order, can_switch_pharmacy, can_choose_new_pharmacy; no subscription state. [LIVE https://generalmedicine.co/cancellation-policy, 2026-10-19]; [CODE lib/store/api/pharmacyOrderApi.ts:15-24,46-59]; [CODE lib/store/api/prescriptionRenewalApi.ts:159-177]; [LIVE https://generalmedicine.co/faq, 2026-10-19: close account via privacy@generalmedicine.co]; [LIVE https://generalmedicine.co/p/lilly/weight-loss, 2026-10-19: “No subscription needed”]
E12 Continuous Does not log weight, doses, or vitals in GM. Weight/waist is captured at visits; labs at the lab; adherence is inferred from refill cadence and self-report. No Withings/Fitbit/Apple Health/Google Fit/Terra/HealthKit integration exists in the recovered client. None. /account/labs shows lab results; /account/medications shows prescriptions; no weight log. Weight/waist only if the patient types it into a questionnaire or the clinician records it; lab biomarkers from lab orders; no device data. [LIVE https://generalmedicine.co/resources/using-a-glp-1-for-weight-loss, 2026-10-19: “Weight and waist size — Every visit”]; [CODE negative: no weight/vitals endpoint in openapi.yaml; no HealthKit/Terra/Withings/Fitbit tokens in source]; [CODE lib/store/api/dashboardApi.ts:27-43: onlyearliest_fill_date/has_pending_criteria, no adherence field]; [DOC adversarial-and-market-report.md §3.6: no App Store/Google Play listing]
E13 Continuous Uses General AI as the between-visit navigator: “I missed a dose”, “I’m having side effects”, “what do these labs mean”, “what’s next in my care plan”. /ai, /ai/onboarding (HIPAA AI consent), /ai/health-records (Metriport/Particle prewarm if gen-ai-prewarm-copilot), /ai/chat. GET/POST /copilot/messages, message_received, message_processing_locked, loading_indicator, consent/status|mark. Session exists/messages_count, consent, chat messages, feedback reaction/category/comment (Braintrust span). [CODE hooks/useGeneralAiStatus.tsx:11-12,58,166-220]; [CODE lib/api/endpoints.ts:309-319]; [CODE components/Refresh/AIPage/IdeasSection/IdeasSection.tsx:11-32]; [CODE lib/store/api/assistantFeedbackApi.ts:1-66]; [LIVE https://generalmedicine.co/ai, 2026-10-19: “trained not to offer diagnosis, medical advice”; async consult 24–48h]; [DOC architecture.md §10.8]
E14 Continuous Receives notifications: in-app Updates badge/feed, email and text for visit links and lab results, refill reminders. No push. /account/updates; GET /updates, /updates/unread_count, POST /updates/read, /updates/read_all; email/SMS for Zoom link and lab results; Twilio OTP/Conversations; Segment/Datadog/LaunchDarkly telemetry. Update event_type, notifiable_type, notifiable_id, unread, created_at, sla_promise, pending_criteria_count, results_count, abnormal_results_count. [CODE lib/store/api/updatesApi.ts:10-19,89-96,112-186]; [LIVE https://generalmedicine.co/using-zoom, 2026-10-19: “secure Zoom link we sent by text and email”]; [LIVE https://generalmedicine.co/api/external/skus/503263, 2026-10-19: “You’ll be notified by email and text”]; [LIVE https://generalmedicine.co/faq, 2026-10-19: “You’ll get a notification as soon as it’s sent”]; [CODE negative: no web push/service worker]; [DOC architecture.md §7.1 vendors 32–37]
E15 D0 and D28 (PA branches) If insured: may be told the drug needs prior authorization; waits “several business days”; if denied, may pay cash or switch. Arrive Health RTPBI at pharmacy selection (arrive_rtpbi_inquiry_id), DoseSpot RTPB/eligibility, payer adjudication. No PA-submission endpoint observed. PA requirement, formulary status, copay tier, arrive_rtpbi_inquiry_id, insurance_status. [CODE lib/store/api/pharmacyOrderApi.ts:90-103]; [DOC architecture.md §9.1 Step 3]; [LIVE https://generalmedicine.co/resources/using-a-glp-1-for-weight-loss, 2026-10-19: “prior authorization … generally takes several business days”]; [LIVE https://generalmedicine.co/api/external/product_detail_pages/710641, 2026-10-19: “Prior authorization is commonly required … we make that process seamless”]; [LIVE https://generalmedicine.co/assignment-of-benefits, 2026-10-19: PA is the patient’s/financially responsible party’s responsibility; patient financially responsible if denied]
E16 Any time Hits an exception: no Rx at the pharmacy, out of stock, PA denied, severe side effect, missed dose, abnormal lab, account blocked, holiday. See §5. — see §5

1.1 Day-by-day summary: what is known vs inferred

day what happens status
D0 (first dose) On the same-day cash path: care plan is sent; prescription becomes a pharmacy order; patient selects pharmacy and billing mode; eRx is transmitted; patient is notified; first fill is picked up/delivered; first injection is self-administered. If the fill takes days (PA, out of stock, mail), D0 shifts to the first dose and the GM-side steps above happen before D0. No GM “first dose” event exists. Known: care plan states/API, pharmacy order/checkout, notification promise, 4-pens-per-month packaging. Inferred/Unknown: click→visit→fill offset; exact hour of fill and first injection; no GM timestamp. [CODE] [LIVE] [PUBLIC] [INFERENCE]
D7 Second weekly dose. No GM event. If the patient has nausea/GI symptoms, they may message, use AI, or book a side-effect visit. Known: once-weekly label; messaging/AI/side-effect SKU exist. Inferred: no reminder or check-in fires on D7. [PUBLIC] [CODE] [INFERENCE]
D14 Third dose. Same as D7. Same.
D21 Fourth dose. After it, all four doses in the 28-day box are used; the next fill is due in 7 days and the refill window is open. GM’s earliest_fill_date and the refill reminder are the only system signals. Known: earliest_fill_date, refill reminder promise, 4 doses per box. Inferred: reminder offset and whether it fires at D21 or later. [CODE] [LIVE] [INFERENCE]
D28 Box exhausted. If escalation is appropriate, the 5 mg box must already be in hand for the next dose. The medication check-in (questionnaire + optional labs) must be complete for a renewal; a clinician review decides 2.5 → 5 mg (or stay/lower/switch); a new Rx and new pharmacy order (and possibly a new PA) follow. Known: check-in routes/APIs, review queue, phase-change ops, label escalation rule, 28-day supply, new-strength price. Inferred: whether GM’s default pathway requires a visit vs questionnaire-only at week 4; exact day the check-in unlocks. [CODE] [PUBLIC] [LIVE] [INFERENCE]

Bottom line on cadence. The public GLP-1 guide is explicit: “Expect monthly check-ins at first while your dose is being adjusted, then a shift to roughly every three months once you’re on a stable dose”, and “Stomach/digestive tolerance check-in — New start, each dose change, then ~every 3 months at a stable dose” [LIVE https://generalmedicine.co/resources/using-a-glp-1-for-weight-loss, 2026-10-19]. The platform implements this as time-gated CareJourney criteria (available_at, locked, deadline) plus NextStepCard deadlines, not as a fixed cron visible to the client [CODE lib/store/api/careJourneyApi.ts:58-71] [CODE lib/store/api/nextStepCardsApi.ts:27-37]. The exact day offsets live in the server-side pathway/criteria set and were not recovered.


1.2 The five models behind the loop (what to build)

model authored / owned what it is how it shows up in weeks 1–4 evidence
CarePathway → CarePathwayPhase → PhaseModality Catalog admin (createCarePathway, publishCarePathway, archiveCarePathway, createCarePathwayPhase, reorderCarePathwayPhases, updateCarePathwayLinkedSkus, createPhaseModality) A versioned clinical protocol: ordered phases, each with modalities and linked SKUs; draft → publish → archive. Visitron reads getPublishedPathways and moves a patient with changePathway / changePhase; batchChangePatientMedicationPhases does it in bulk. [INFERENCE] The 2.5 mg → 5 mg step at week 4 is likely a phase change (and therefore a new linked SKU/strength, prescription and fill) because Visitron exposes changePhase/batchChangePatientMedicationPhases; the actual GLP-1 pathway/phase bindings were not recovered, so this is not an observed fact. [DATA osint/internal_portals_recon.json → catalog.rtk_endpoints, visitron.rtk_endpoints]; [DOC architecture.md §8.3, §8.2]
Care::Plan Visitron (AI draft → clinician review → confirmCarePlan) The per-encounter plan object: provider_message, patient_instructions, next steps, state (awaiting_curation … sent). The patient’s home page shows the plan and its next steps; care_plan_ready is an Updates event; patient_rationale explains “why this”. [CODE lib/store/api/carePlanApi.ts:7-22]; [CODE components/CareActions/careActionSection.ts:65-79]; [DOC architecture.md §8.2]
CareJourney criteria Server-side criteria set (Catalog CriteriaSet/Requirement; not recovered) A checklist of Lab / Questionnaire / Visit criteria with status, locked, available_at, deadline, estimated_minutes, medication names, and lab-bundle metadata. This is the check-in engine. The /account/medication-check-in hub, the Care Journey questionnaire/lab landings, and the medication_check_in care action. [CODE lib/store/api/careJourneyApi.ts:39-77]; [CODE lib/careJourney/checklist.ts:8-59]; [CODE components/CareActions/careActionSection.ts:154-165]
NextStep / NextStep::PrescriptionRenewal + NextStepCard Server-side; Visitron createPatientMedicationPrescriptionRenewal; patient snooze/dismiss The actionable queue. Eight card kinds: video_visit_follow_up, lab_order, questionnaire, imaging_order, referral_order, in_person_visit_order, prescription_order, medication_check_in. Renewal carries due_date, on_next_step, open_to_renew. The Next Steps queue; the week-4 renewal/check-in card; the “caught up” state. [CODE lib/store/api/nextStepCardsApi.ts:6-45]; [CODE lib/store/api/prescriptionRenewalApi.ts:5-22]; [CODE lib/store/api/prescriptionApi.ts:10-20]
PharmacyOrder Created by ensure_pharmacy_order; patient selects/pays; pharmacy fulfills The dispense object: state, billing_type, cash_price, insurance_price, NCPDP id, cancel/switch flags. The first fill and every subsequent fill; the gm_card counter pass. [CODE lib/store/api/pharmacyOrderApi.ts:15-24,26-118]; [DOC architecture.md §9.1]

Check-in price. The check-in itself (questionnaire + lab criteria) is not a visit and has no separate visit fee in the recovered contract; it is a criteria flow on the prescription. The $25 / $30 / $100 grid applies only when a criterion is a Visit, or when the patient books a follow-up (300550), side-effect (300348), adjustment (200010), care video check-in (300591), or follow-up video visit (400015) [CODE lib/store/api/careJourneyApi.ts:46-56] [LIVE https://generalmedicine.co/api/external/sku_options/300550, /300348, /200010, /300591, /400015, 2026-10-19].

2. Handoffs table

Every GM↔outside-party exchange on this path. “Direction” is data flow, not money flow.

id step counterparty (company + product) direction what is exchanged (fields) mechanism trigger who pays / fee evidence
H1 E7 Emerald Medical Practice P.C. (AZ/CA/KS), Centennial Medical Practice P.C. (ID), Ruby Medical Practice P.C. (NJ) — the professional corporations; Path Healthcare Systems Corp. is the administrative/management company (MSO role inferred) GM → PC / PC → GM Clinician identity, encounter, orders, care plan, prescription; the PC is the billing/furnishing entity Internal employment/contract + Visitron/Athena; patient consent names the PCs Visit, check-in review, dose change Patient pays GM; the PC/clinician is paid by GM (contract terms undisclosed) [LIVE https://generalmedicine.co/telehealth-informed-consent, 2026-10-19: “Emerald … Centennial … Ruby … collectively ‘Emerald’”; “Path … does not provide the Services”]; [LIVE https://generalmedicine.co/assignment-of-benefits, 2026-10-19: “Emerald Medical Practice P.C. (the ‘Practice’)”]; [DOC architecture.md §7.5]
H2 E1–E8 OpenLoop Health / Vital and affiliate PCs (Reliant.MD, MECNB) GM → clinician network / network → GM Telehealth consultation furnished by an OpenLoop-affiliated PC; clinician identity/credentials Separate telehealth consent page (/vital-informed-consent); provider network If the visit is routed to the OpenLoop network Patient pays GM; OpenLoop/PC paid by GM (undisclosed) [LIVE https://generalmedicine.co/vital-informed-consent, 2026-10-19: “Vital and affiliate Openloop Healthcare Partners, PC offer Telehealth consultations … Reliant.MD … MECNB”]; [DOC architecture.md §7.1 vendor 5]
H3 E1, E8 DoseSpot GM ⇄ DoseSpot Patient context, eligibility inquiry, formulary, draft/final prescription, EPCS identity SSO redirect (dose_spot_sso) + REST (prescription_eligibility_inquiries/*) + NCPDP SCRIPT (attributed) Clinician prescribes / renews / changes dose GM pays SaaS; patient pays visit + drug [DOC architecture.md §7.1 vendor 2, §8.2]; [DATA osint/internal_portals_recon.json → visitron.api_paths: /dose_spot_sso, /dose_spot/prescription_eligibility_inquiries/]
H4 E1.1, E15 Arrive Health GM ⇄ Arrive Patient + drug + pharmacy → copay tier, deductible, formulary, prior-auth requirement; returns arrive_rtpbi_inquiry_id REST launch_benefit_inquiry, patient_context?patient_id= Pharmacy selection (before transmission) GM pays SaaS; patient pays copay/cash [CODE lib/store/api/pharmacyOrderApi.ts:90-103]; [DOC architecture.md §9.1 Step 3]
H5 E1, E7 Athenahealth GM ⇄ Athena Encounter note, diagnoses, care plan, chart summary, athena_id Visitron sync_encounter_to_athena, care_plan_athena_resync, encounter_summary_athena_resync Clinician signs/publishes; care plan changes GM pays SaaS [DOC architecture.md §7.1 vendor 1, §8.2]; [DATA … → visitron.rtk_endpoints]
H6 E13 Metriport + Particle Health GM ⇄ HIE Longitudinal records, prior prescriptions, labs, conditions, allergies; digested review injected into copilot context REST health_history/latest_metriport, trigger_metriport_sync, send_metriport_review_to_copilot AI prewarm (gen-ai-prewarm-copilot) or clinician prewarm GM pays per retrieval [CODE lib/api/endpoints.ts:268-274]; [DOC architecture.md §7.1 vendors 27–28, §10.8]; [LIVE https://generalmedicine.co/faq, 2026-10-19: HIE records with consent]
H7 E1.2–E1.4, E8–E9 LillyDirect Pharmacy (NCPDP 1574056) GM → LillyDirect (eRx); LillyDirect → patient (drug) NCPDP provider id, drug/strength/quantity/days supply, patient shipping/identity, payment; no dispense status back in the recovered client contract (whether GM receives a separate fill/dispense feed from LillyDirect or the PBM is Unknown — see §6) eRx via NCPDP SCRIPT (attributed); GM cash checkout via Stripe (who captures/remits not observed); LillyDirect ships Patient selects LillyDirect; cash path Patient pays LillyDirect/GM $299/$399/$449; needles extra; GM routing margin unknown [LIVE https://generalmedicine.co/api/external/pharmacy_comparisons?medication_option_sku_id=710641…, 2026-10-19]; [PUBLIC https://www.lilly.com/lillydirect/zepbound]; [DOC architecture.md §9.1]
H8 E1.2–E1.4, E8–E9 Amazon Pharmacy (NCPDP 5919177) GM → Amazon (eRx); Amazon → patient Same as H7 eRx + Amazon delivery Patient selects Amazon; cash path Patient pays $299/$399/$449; GM margin unknown [LIVE https://generalmedicine.co/api/external/pharmacy_comparisons?medication_option_sku_id=710641…, 2026-10-19]; [CODE components/Refresh/SearchResults/searchPharmaciesUtils.ts:72-134]
H9 E1.2–E1.4, E8–E9 CVS / Walgreens / Walmart / Costco / Safeway / Kroger / Rite Aid / Alto GM → pharmacy (eRx); pharmacy → patient NCPDP id, drug/strength/quantity/days supply, billing type (cash/insurance/pharmacy_delegation), gm_card BIN/PCN/group/member eRx via NCPDP SCRIPT (attributed); retail pickup; claim adjudication through the pharmacy switch Patient selects retail; cash/insurance/delegation Patient pays cash price or insurance copay at counter; GM may earn routing margin (unknown) [LIVE https://generalmedicine.co/api/external/pharmacy_comparisons?medication_option_sku_id=710641…, 2026-10-19]; [CODE components/Refresh/SearchResults/searchPharmaciesUtils.ts:1-134]; [DOC architecture.md §9.1]
H10 E1.3, E8 Stripe GM ⇄ Stripe SetupIntent, payment_method_id, card charge, 3DS, refunds REST + Stripe.js/Elements; create_stripe_setup_intent, previous_fill_payment_method Cash/gm_card checkout; visit booking Patient pays; GM pays processing [CODE lib/api/endpoints.ts:321-329]; [CODE lib/store/api/paymentServiceApi.ts:18-21]; [DOC architecture.md §7.1 vendor 30]; [LIVE https://generalmedicine.co/privacy-policy, 2026-10-19: “Our payment processor is Stripe”]
H11 E3, E14 Twilio GM ⇄ Twilio Chat/conversation token, messages, attachments, OTP SMS Twilio Conversations (JWT) + Cognito CUSTOM_AUTH → Twilio Lambda for OTP; SMS short code 98528 Patient messages / logs in / receives OTP GM pays per message/OTP; patient pays carrier SMS [CODE lib/api/endpoints.ts:59-67]; [CODE lib/store/api/messageCenterApi.ts:168-175]; [DOC architecture.md §7.1 vendor 32, §10.7]; [LIVE https://generalmedicine.co/api/external/tenant_integrations/phone_number → 98528, 2026-10-19]
H12 E14 Zoom GM → patient Unique meeting_url, meeting id/passcode Link sent by SMS and email; Zoom app/browser Video visit booked GM pays Zoom; patient pays visit [CODE lib/api/endpoints.ts:82-93]; [LIVE https://generalmedicine.co/using-zoom, 2026-10-19]; [DOC architecture.md §7.1 vendor 33]
H13 E6 Quest Diagnostics / Labcorp / BioReference GM → lab (order); lab → GM (results) Test codes, requisition, accession number, result PDF/HL7/FHIR, clinical_fee Lab order via GM; PSC draw; results to EHR/dashboard; external PDF upload to S3 Check-in labs or baseline labs Patient pays GM (panel + $15 clinical fee); GM pays lab wholesale [CODE lib/api/endpoints.ts:249-252]; [LIVE https://generalmedicine.co/api/external/lab_skus/503263, 2026-10-19]; [DOC architecture.md §9.2]
H14 E6 AWS S3 (or Nile-Core, depending on transport) Patient browser → S3 → GM External lab PDF bytes, file id, presigned URL, upload state/ready, then the check-in completion Direct-S3 path: POST /file_uploads/presign → browser PUT to S3 → POST /file_uploads/{id}/complete (marks the upload ready) → POST /care_journey/complete_lab_upload (finalizes the check-in). Legacy path: base64 JSON → POST /file_uploads on Nile-Core. The check-in page’s chosen transport is not recovered; direct-S3 is a tenant capability (directToS3FileUpload). Patient chooses “upload my labs” instead of drawing Patient pays nothing extra; GM pays storage [CODE lib/fileUpload/directUpload.ts:1-90 (presign → S3 PUT → file_uploads/{id}/complete)]; [CODE lib/store/api/fileUploadApi.ts:88-140 (legacy base64 vs direct-S3)]; [CODE lib/api/endpoints.ts:225-233]; [CODE lib/store/api/careJourneyApi.ts:161-177]; [DOC architecture.md §9.2, §11.3]
H15 E14 Email provider (unidentified) GM → patient Visit link, lab-result notice, prescription-sent notice, care-plan notice Email (SMTP/API vendor not observed) Visit booked; lab resulted; Rx sent GM pays vendor [LIVE https://generalmedicine.co/using-zoom, 2026-10-19: link sent by text and email]; [LIVE https://generalmedicine.co/api/external/skus/503263, 2026-10-19: notified by email and text]; [CODE negative: no SendGrid/Postmark/Mailgun/Klaviyo/CIO/Braze token]; vendor Unknown
H16 E13 Braintrust GM → Braintrust AI span scoring, thumbs-up/down category/comment /api/chat/feedback → server-side span score Patient rates an AI answer GM pays [CODE lib/store/api/assistantFeedbackApi.ts:1-66]
H17 E14 Segment / Datadog / LaunchDarkly / Metabase + Databricks GM → vendors Product events, RUM/session replay, flag evaluations, BI SDK/JS + server pipeline Every page/flag/error GM pays [CODE packages/mantine-theme/analytics/events.ts:1-60]; [CODE lib/analytics/datadogRum.ts]; [DOC architecture.md §7.1 vendors 35–37, §8.7]
H18 E2, E16 Eli Lilly (IFU, Medication Guide, savings program, MedWatch) Lilly → patient; patient → Lilly/FDA Instructions for Use, Medication Guide, savings enrollment, adverse-event report Paper insert / LillyDirect / Lilly call center 1-800-LillyRx; FDA MedWatch First fill; side effect; savings Patient pays (drug/needles); Lilly may subsidize [PUBLIC https://pi.lilly.com/us/zepbound-uspi.pdf: “To report SUSPECTED ADVERSE REACTIONS, contact Eli Lilly … or FDA at 1-800-FDA-1088”]; [PUBLIC https://www.lilly.com/lillydirect/zepbound: savings automatically applied through LillyDirect]

3. Ops touchpoints (human action)

role queue / tool what they do on this path trigger SLA if known evidence
Prescriber (MD/NP) Visitron encounter Reviews prewarmed chart, examines/talks, diagnoses, prescribes, signs encounter, confirms care plan Initial GLP-1 visit; follow-up; side-effect/adjustment visit Visit availability “today” for video on 300543/300550; async review 24–48h for new AI customers [CODE lib/api/endpoints.ts:82-93]; [LIVE https://generalmedicine.co/api/external/sku_options/300543 → video availability_promise “today”, 2026-10-19]; [LIVE https://generalmedicine.co/ai: 24–48h]; [DOC architecture.md §8.2]
Check-in reviewer Visitron getPendingReview, createNextStepReview, generateNextStepReview, updateNextStepReview, applyReview, rejectReview, confirmCarePlan, confirmNoChange Reviews the week-4 questionnaire/labs; accepts/edits/rejects the AI-drafted next-step review; decides dose change Medication check-in completed (or lab resulted) No SLA observed [DATA osint/internal_portals_recon.json → visitron.rtk_endpoints]; [DOC architecture.md §8.2]
Prescriber doing the dose change Visitron changePhase, changePathway, batchChangePatientMedicationPhases, createPatientMedicationPrescriptionRenewal, updatePatientMedicationDaysSupply, clearPatientMedicationDaysSupply, updatePatientMedicationCourseType Changes the patient’s medication phase/strength, writes the new Rx, sets days supply/course type; may create the renewal next step Week-4 review; intolerance; plateau; switch No SLA observed [DATA … → visitron.rtk_endpoints]; [DOC architecture.md §8.2]
Inbound refill reviewer Visitron listInboundRequests, approveInboundRequest, denyInboundRequest Approves/denies pharmacy-initiated refill/renewal requests (the pharmacy asks the prescriber) Pharmacy sends an inbound request at/near the refill date Public claim: “most refill requests … reviewed and confirmed the same day” [DATA … → visitron.rtk_endpoints]; [DOC architecture.md §8.2]; [LIVE https://generalmedicine.co/resources/medication-faqs, 2026-10-19]
Care team / support agent SMS 98528; Message Center /account/messages (Twilio); help@/hello@/support@navhealth.co Answers “where is my Rx”, side-effect questions, billing/refund questions, reschedules; routes clinical questions to a clinician Patient texts/messages/emails; pharmacy failure Per-thread response_expectation (server-driven, e.g. “Clinician will respond within 2 hours” per dossier); support hours M–F 9–9 ET / 7–7 MT except federal holidays [CODE hooks/useContactSupport.ts:10,59-92]; [CODE lib/store/api/messageCenterApi.ts:44-58]; [LIVE https://generalmedicine.co/faq: M–F 9–9 ET]; [LIVE https://generalmedicine.co/telehealth-informed-consent: M–F 7–7 MT except federal holidays]; [DOC architecture.md §10.7]
Clinical reviewer for abnormal labs Visitron lab/result review; Updates abnormal_results_count Reaches out to the patient when levels are out of range; recommends next step Lab resulted abnormal No SLA; “will reach out” [CODE lib/store/api/updatesApi.ts:86-88]; [LIVE https://generalmedicine.co/resources/labs-faqs, 2026-10-19]
Pharmacy staff Retail/specialty pharmacy Counsels on injection at pickup; adjudicates claim; may send an inbound refill request; may report out-of-stock First fill; refill; PA No GM SLA [PUBLIC https://pi.lilly.com/us/zepbound-uspi.pdf §2.4: train patients on presentation]; [DOC architecture.md §9.1]; [DATA … → visitron.rtk_endpoints: listInboundRequests]
Prior-auth / RCM No dedicated PA tool observed; Arrive Health RTPBI + DoseSpot RTPB + Waystar claims; Visitron notes Works the PA, documents, re-runs benefit check; may switch drug/pharmacy PA required/denied; dose change Public: “several business days” [LIVE https://generalmedicine.co/resources/using-a-glp-1-for-weight-loss, 2026-10-19]; [DOC architecture.md §7.1 vendors 6–7, §9.1]; [INFERENCE] manual/fax/ePA workflow; no PA endpoint recovered
AI / prompt engineer Provider Chat / Promptimus; Braintrust; Datadog Tests/tunes the copilot prompt, model version, temperature; reviews thumbs-down clusters AI quality issue; new clinical content None [DOC architecture.md §8.5, §10.8]; [CODE lib/store/api/assistantFeedbackApi.ts]
Growth / lifecycle Segment, Datadog, Metabase; no marketing-automation tool observed Watches dashboard/check-in/refill funnel; manual outreach if at all Refill lapse; check-in non-completion None [CODE packages/mantine-theme/analytics/events.ts:44-52]; [DOC architecture.md §8.7]; [INFERENCE] no Braze/Iterable/Klaviyo observed

Staffing implication. The only productized clinical queues on this path are Visitron’s next-step review and inbound-request queues. There is no observed GLP-1-specific adherence queue, no refill-lapse queue, and no after-hours clinical triage queue. The support surface is a short code, an in-app chat (flagged), and three email addresses across two domains (help@generalmedicine.co, hello@generalmedicine.co, support@navhealth.co), plus two published phone numbers ((801) 251-6055 in the footer, (801) 255-6051 in the telehealth consent for technical failure) [LIVE https://generalmedicine.co/telehealth-informed-consent] [LIVE https://generalmedicine.co/faq].


4. Money (month 1)

4.1 Visit fees (the only GM-controlled recurring charge)

item cash insurance evidence
GLP-1 medication evaluation (300543) — video $100 $25 typical copay [LIVE https://generalmedicine.co/api/external/sku_options/300543, 2026-10-19]; [LIVE https://generalmedicine.co/s/glp-1-medication-evaluation/300543: “Video Visit $25 Est. or $100 w/o insurance · Chat Visit $30 w/o insurance”]
GLP-1 medication evaluation — chat $30 not offered same
Weight loss follow-up (300550) — video / chat $100 / $30 $25 [LIVE https://generalmedicine.co/api/external/sku_options/300550]; [LIVE https://generalmedicine.co/s/weight-loss-follow-up/300550]
Medication side effect (300348) — video / chat $100 / $30 $25 [LIVE https://generalmedicine.co/api/external/sku_options/300348]; [LIVE https://generalmedicine.co/s/medication-side-effect/300348]
Medication adjustment (200010) — video only $100 $25 [LIVE https://generalmedicine.co/api/external/sku_options/200010]; [LIVE https://generalmedicine.co/s/medication-adjustment/200010]
Care video check-in (300591) — video only $100 $25 [LIVE https://generalmedicine.co/api/external/sku_options/300591]; [LIVE https://generalmedicine.co/api/external/skus/300591: “A short conversation with your clinician to finalize your care.”]
Follow-up video visit (400015) — video only $100 $25 [LIVE https://generalmedicine.co/api/external/sku_options/400015]
Prescription renewal (200007 / 400020) — video / chat $100 / $30 $25 [LIVE https://generalmedicine.co/api/external/sku_options/200007, /400020]; [LIVE https://generalmedicine.co/s/prescription-renewal/200007: same grid]

The $25 is a typical copay estimate, not a guarantee: the canonical constant is TYPICAL_VISIT_COPAY_CENTS = 2500, matching Nile-Core Sku::TYPICAL_COPAY [CODE lib/productDetailPage/resolveMedicationOptionVisitCost.ts:4]. The PDP labels it “typical copay” for logged-out visitors and “est. insurance price” for authenticated patients [CODE components/ProductDetailPage/MedicationPriceCard.tsx:14-19,30-45].

Price presentation nuance. The bulk prices endpoint returns, for 300543/300550/300348, top-level cash $30 and insurance $25 with primary: true on insurance (the minimum cash option is chat) [LIVE https://generalmedicine.co/api/external/sku_options/prices?sku_ids[]=300543…, 2026-10-19]. The visit SKU card therefore advertises “$30 without insurance” while the video option is $100. The visit-options page disambiguates. This is a real price-shock risk for uninsured video patients.

4.2 Medication (the dominant month-1 cost)

presentation 2.5 mg 5 mg 7.5–15 mg evidence
Zepbound KwikPen (710641/710643/710644…) $299 $399 $449 [LIVE https://generalmedicine.co/api/external/medication_option_skus/710641/cash_price?zip_code=94107 → 29900; 710643 → 39900; 710644 → 44900, 2026-10-19]
Zepbound single-dose pen / auto-injector (710642…) $1,074.09 $1,074.09 $1,074.09 [LIVE …/710642/cash_price → 107409; 710646/710649 → 107409, 2026-10-19]
Zepbound vial (701542, 706142, …) no cash price no cash price no cash price [LIVE …/701542/cash_price → null, 2026-10-19]
Retail cash (2.5 mg) Walgreens/Costco/Safeway/Walmart $496.12; CVS $508.09 $496.12 / $508.09 $496.12 / $508.09 [LIVE https://generalmedicine.co/api/external/pharmacy_comparisons?medication_option_sku_id=710641&latitude=37.7749&longitude=-122.4194, 2026-10-19]
LillyDirect/Amazon cash $299 $399 $449 same live endpoint

The KwikPen cash ladder is the LillyDirect self-pay ladder, not a GM invention: 2.5 mg $299/mo, 5 mg $399/mo, 7.5–15 mg $449/mo when you refill within 45 days; late refills are $499 (7.5) / $699 (10–15). A “month” is 28 days and 1 single-patient-use KwikPen; pen needles are a separate purchase [PUBLIC https://www.lilly.com/lillydirect/zepbound]. Single-dose pens include the needle; with commercial insurance the single-dose pen can be “as low as $25/month for up to a 3-month prescription” through the savings card [PUBLIC same].

This is the single most important week-4 economic fact: escalating 2.5 → 5 mg raises the cash price $299 → $399 at LillyDirect/Amazon, while retail cash stays ~$496–$508. A patient who chose the single-dose pen instead of the KwikPen sees $1,074.09 at cash checkout — 3.6× the KwikPen. Presentation selection is therefore a cost decision, not a cosmetic one.

What the patient sees before the visit: “With insurance — Available after visit” (tooltip: “Your insurance price is set by your specific plan, so we can only check it once you have a prescription”), plus the drug cash price and a “+ $25 typical copay for visit” footer [CODE components/ProductDetailPage/MedicationPriceCard.tsx:14-45,110-130] [LIVE https://generalmedicine.co/api/external/product_detail_pages/710641: “insurance price is never resolvable on the PDP” comment in code]. Insurance price is only resolved after the prescription exists and the pharmacy is selected.

4.3 Labs (only if the check-in requires them)

item cash evidence
Comprehensive GLP-1 Lab Panel (503263) — Quest $86.58 total ($71.58 test + $15.00 clinical fee) [LIVE https://generalmedicine.co/api/external/lab_skus/503263, 2026-10-19]
same — Labcorp $109.67 ($94.67 + $15.00) same
same — BioReference $102.20 ($87.20 + $15.00) same
Insurance price null on all three (displayed as “Priced after visit” / estimated copay) same; [CODE lib/store/api/pharmacyOrderApi.ts:73-88]

The panel is 5 tests (CMP, lipid, TSH w/ reflex Free T4, CBC, HbA1c), “Results in 48 hours, expertly reviewed” [LIVE …/lab_skus/503263]. The $15.00 is the live server-driven clinical fee; $30 is only the client fallback when the fee is missing [CODE types/enums/lab-pricing-constants.ts:8] [DOC adversarial-and-market-report.md §1.5].

4.4 Rules and non-charges

rule amount / behavior evidence
Subscription None. “No subscription needed.” Refill ordering is always the patient’s step; GM does not auto-charge. [LIVE https://generalmedicine.co/p/lilly/weight-loss]; [CODE lib/hardcoded-data/CategoryPages/medications.ts:156-157]
Auto-refill No auto-charge. GM notifies, patient reorders; payment method/pharmacy can change before ordering. same
Cancellation fee Charged to card on file for <24h cancellation/no-show; Medicaid patients exempt; reschedule free; visit fee refunded in 5–10 business days; no refunds for services provided or for the fee itself. [LIVE https://generalmedicine.co/cancellation-policy, 2026-10-19]
Lab refund Full refund up to 6 months if the sample has not been collected; no fee deduction; same across labs; request by SMS 98528 or support@navhealth.co. [LIVE https://generalmedicine.co/refund-policy-labs, 2026-10-19]
Prior auth “Several business days”; PA is legally the patient’s/financially responsible party’s responsibility; patient financially responsible if denied or retrospectively deemed not medically necessary. [LIVE https://generalmedicine.co/resources/using-a-glp-1-for-weight-loss]; [LIVE https://generalmedicine.co/assignment-of-benefits]
HSA/FSA Eligible for visits and labs. [LIVE https://generalmedicine.co/faq]
Clinical review fee on a pharmacy order clinical_fee_cents exists and is charged separately; amount not observed. [CODE lib/utilities.ts:949-979]; [DOC architecture.md §9.1]
Pharmacy routing fee Unknown; GM may earn a margin on gm_card/routing. [INFERENCE]; [DOC adversarial-and-market-report.md §3.4]

4.5 Illustrative month-1 totals (cash, no insurance)

scenario visit drug labs total
Video visit, KwikPen 2.5 mg at LillyDirect, no labs $100 $299 $0 $399
Chat visit, KwikPen 2.5 mg at LillyDirect, GLP-1 panel at Quest $30 $299 $86.58 $415.58
Video visit, KwikPen 2.5 mg at retail (Walgreens), no labs $100 $496.12 $0 $596.12
Video visit, single-dose pen at cash list, no labs $100 $1,074.09 $0 $1,174.09
Through the week-4 second fill: video visit + week-4 follow-up + initial 2.5 mg box + escalated 5 mg box, no labs $200 $698 ($299 + $399) $0 $898

These are arithmetic on observed prices, not quotes [INFERENCE] for the totals. Month-1 spend alone (initial visit + first box) is $399 in the cheapest row; the week-4 follow-up and second box are next-cycle costs. Through the second fill the cheapest total is $898 ($200 visits + $698 drug). The point is the spread: $399 to $1,174 for the first month depending on modality, presentation and pharmacy.


5. Failure modes & branches

branch / failure what happens who acts evidence
Pharmacy never receives the eRx / patient sees no Rx The client has no “pharmacy received/acknowledged” endpoint and no dispense feed. The order exposes state plus can_cancel_pharmacy_order / can_switch_pharmacy / can_choose_new_pharmacy; the practical remedy is cancel + re-route. The patient is the error detector (call/text). Patient + care team; maybe prescriber re-send [CODE lib/store/api/pharmacyOrderApi.ts:15-24,46-59]; [LIVE https://www.bbb.org/... and https://uk.trustpilot.com/review/generalmedicine.co?page=4 via DOC adversarial-and-market-report.md §3.6: “visited the pharmacy 3 times, with no prescription in my name”]; [INFERENCE] no NCPDP dispense/ack status observed
Out of stock (GLP-1 pen) No inventory API observed. The compare drawer pins LillyDirect/NovoCare and Amazon as cold-chain/mail alternatives and interleaves 2 retail : 1 online, so the patient can switch. cancel {pharmacy_change: true } reopens the compare drawer with can_choose_new_pharmacy: true. Patient + pharmacy + care team [CODE components/Refresh/SearchResults/searchPharmaciesUtils.ts:72-134]; [CODE lib/store/api/pharmacyOrderApi.ts:46-59]; [DOC architecture.md §9.1 Step 7]
PA required RTPBI returns the PA requirement at pharmacy selection. GM markets “seamless” PA, but the legal terms put PA responsibility and denial risk on the patient. Work takes “several business days.” PA/RCM + prescriber + patient [CODE lib/store/api/pharmacyOrderApi.ts:90-103]; [LIVE PDP FAQ]; [LIVE AOB]; [LIVE GLP-1 article]
PA denied Options: cash (LillyDirect $299+), switch drug/strength, or appeal. The visit fee is not refunded (“no refunds for services we have provided”). Patient + prescriber + PA team [LIVE cancellation policy]; [LIVE PDP FAQ: Medicare Part D often does not cover weight management alone]
Insurance does not cover weight loss Cash path is shown after the visit; LillyDirect/Amazon $299/$399/$449; retail $496–$508. Patient [LIVE PDP FAQ]; [LIVE comparisons]
Dose escalation not tolerated / patient wants to stay at 2.5 mg Clinician can keep the current phase, lower it, or switch. The label says 2.5 mg is not a maintenance dose; the follow-up FAQ says the clinician walks through “increasing versus staying.” Prescriber [PUBLIC label §2.1]; [LIVE https://generalmedicine.co/s/weight-loss-follow-up/300550]
Dose escalation requires a new PA New strength = new NDC; a new PA/step-therapy edit is common. The new fill can be delayed past day 28; the patient may miss a dose. PA/RCM + prescriber + patient [INFERENCE] based on new medication_option_sku_id + RTPBI + “several business days”; [CODE lib/store/api/pharmacyOrderApi.ts:90-103]
Severe GI side effect (nausea/vomiting/diarrhea, dehydration) Message/care team, book 300348 Medication Side Effect (video $100/$25, chat $30) or 200010 Medication Adjustment (video $100/$25); clinician may hold/lower dose or stop. Emergency → 911; GM’s providers “do not address medical emergencies.” No 24/7 clinical line observed. Patient + care team + prescriber [LIVE https://generalmedicine.co/s/medication-side-effect/300348]; [LIVE https://generalmedicine.co/s/medication-adjustment/200010]; [LIVE https://generalmedicine.co/telehealth-informed-consent: emergency instructions, M–F hours]; [PUBLIC label §5.2–5.3]
Patient stops the drug abruptly The side-effect FAQ explicitly says do not stop abruptly without clinical guidance (for the drug classes listed); GLP-1 is not in that list but the advice is generic. No GM “stop treatment” workflow. Patient + prescriber [LIVE https://generalmedicine.co/s/medication-side-effect/300348 FAQ]; [PUBLIC label §8.1: discontinue when pregnancy is recognized]
Missed dose Label: take within 4 days (96 h); if more, skip and resume the regular day; the dosing day can change if ≥3 days between doses. GM has no automated missed-dose flow; the AI example prompt covers it. Patient; AI/messaging for guidance [PUBLIC label §2.3]; [CODE components/Refresh/AIPage/IdeasSection/IdeasSection.tsx:27]
Check-in not completed The prescription shows has_pending_criteria / criteria_deadline; the renewal is gated. No auto-refill. The patient can snooze/dismiss the card (dismissal ≠ completion). Patient + care team [CODE lib/store/api/dashboardApi.ts:27-43]; [CODE lib/store/api/nextStepCardsApi.ts:98-171]; [INFERENCE] dismissal leaves criteria pending
Check-in labs not drawn / external PDF instead Patient can upload an external PDF. Direct-S3 path: presign → S3 PUT → file_uploads/{id}/complete → care_journey/complete_lab_upload → progress; legacy path posts base64 to Nile-Core. The check-in page’s transport is not recovered; either way the file is then attached/shared for review. Patient + clinical reviewer [CODE lib/fileUpload/directUpload.ts:1-90]; [CODE lib/store/api/fileUploadApi.ts:88-140]; [CODE lib/api/endpoints.ts:225-233]; [CODE lib/store/api/careJourneyApi.ts:161-177]; [DOC architecture.md §9.2]
Abnormal lab A licensed clinician reviews; if out of range, the clinical team reaches out directly to review and recommend next steps. Clinical reviewer [LIVE https://generalmedicine.co/resources/labs-faqs, 2026-10-19]; [CODE lib/store/api/updatesApi.ts:86-88]
Refill lapse >45 days (≥7.5 mg at LillyDirect) Price jumps from $449 to $499 (7.5) or $699 (10–15). Patient [PUBLIC https://www.lilly.com/lillydirect/zepbound]
Refill lapse (any dose) No auto-refill; the patient runs out; no adherence outreach observed. Patient; no queue [CODE lib/hardcoded-data/CategoryPages/medications.ts:156-157]; [INFERENCE]
Cancellation <24h Fee charged to card on file; Medicaid exempt; visit fee refunded 5–10 business days; reschedule free. Patient + support [LIVE https://generalmedicine.co/cancellation-policy]
Pharmacy order cancel/switch POST /pharmacy_orders/{id}/cancel {pharmacy_change} returns cancel/switch/choose-new flags; when pharmacy_change is true the backend voids NCPDP routing and reopens compare. Patient self-serve [CODE lib/store/api/pharmacyOrderApi.ts:46-59]; [DOC architecture.md §9.1 Step 6]
Decline a renewal POST /next_step_prescription_renewals/{id}/decline {cancellation_reason}; or completed_elsewhere; invalidates prescription/dashboard. Patient [CODE lib/store/api/prescriptionRenewalApi.ts:159-177]
Account blocked The dashboard renders only a notice, no shell/nav. Cause not exposed to the client. Support [CODE hooks/useAccountDashboardActive.ts:8-16 comment: “Blocked accounts render only a notice with no dashboard chrome”]
Support closed (weekend/federal holiday) No 24/7 clinical line; emergency is 911. Visits may still be available after hours/weekends depending on clinician supply. Patient [LIVE consent: M–F 7–7 MT except federal holidays]; [LIVE FAQ: visits often available after hours/weekends]
Walmart tenant General AI is hard-disabled (generalAi:false), direct SMS to care team is disabled (textCareTeam:false); the patient is routed to portal/phone and the Walmart app. this file’s DTC behavior does not apply. Tenant config [CODE config/tenants/walmartPublic.ts:42-50]; [DOC architecture.md §11.3]

The failure pattern to plan for. GM’s clinical workflow is more instrumented than its fulfillment workflow. The clinical side has queues, AI drafts, reviews and escalation SKUs. The pharmacy side has a one-way transmission, three cancel flags, and no acknowledgment/dispense feed in the recovered client contract (whether a server-side feed exists is Unknown — see §6). The 1★ review tail (“no prescription in my name”) is exactly this gap [DOC adversarial-and-market-report.md §3.6].


6. Open questions

  1. Exact week-4 trigger. Does the GLP-1 pathway require a visit (300550 / 400015 / 300591), a questionnaire only, or questionnaire + labs before the next fill? The CareJourney model supports all three types and time gates (available_at, locked, deadline), but the GLP-1 criteria set is server-side and was not recovered. [CODE lib/store/api/careJourneyApi.ts:58-71]
  2. Check-in day offsets. Is the first check-in at day 28, day 30, or “before the next fill”? The public guide says monthly; the code has no fixed cron. [LIVE GLP-1 article] [CODE]
  3. Questionnaire content and length. The check-in is a multi-question questionnaire with questionnaire_length and progress, but the question text and count are not in the recovered tree and the live /api/external/questions/{id}/{n} returns 401. [CODE lib/store/api/careJourneyApi.ts:130-138]
  4. Which labs the GLP-1 check-in bundles. 503263 is explicitly “Monitor … while on GLP-1 therapy” and is the obvious candidate, but the bundle is per-prescription (patient_medications/{id}/lab_bundle) and the actual skus[] list was not observed. [LIVE 503263] [CODE lib/store/api/prescriptionApi.ts:54-71]
  5. Who reviews the check-in. Any on-call clinician, the prescriber, or a dedicated GLP-1 panel? Visitron has a generic pending-review queue; there is no GLP-1-specific assignment observed. [DATA visitron.rtk_endpoints]
  6. Email/SMS delivery vendor and templates. Twilio covers OTP/Conversations; the email vendor is not identified in the client, and the exact refill-reminder channel/cadence is unknown. [CODE negative]
  7. PA submission mechanism and turnaround. No PA-submission endpoint was observed; Arrive Health/DoseSpot return the requirement, Waystar handles claims, but who submits the PA (ePA, fax, portal) and the real median turnaround are unknown. [CODE] [DOC §7.1]
  8. Clinical review fee on pharmacy orders. clinical_fee_cents exists; the amount and whether GLP-1 orders carry it are unknown. [CODE lib/utilities.ts:949-979]
  9. Cancellation fee amount. The policy says a fee is charged but does not publish the amount. [LIVE cancellation policy]
  10. Whether GM earns a pharmacy routing margin. The gm_card and pharmacy delegation imply a switch relationship; the economics are undisclosed. [DOC adversarial-and-market-report.md §3.4] [INFERENCE]
  11. Whether the AI copilot can see the active prescription/dose. The chat has a health-details modal with HealthMedication {name, dose_value} and Metriport prewarm, but the prompt context and whether it includes the current GM prescription are not in the recovered client. [CODE components/HealthDetailsModal.tsx:41] [CODE hooks/useGeneralAiStatus.tsx]
  12. Whether care-team messages are answered by a licensed clinician. The UI says “care team”; the dossier says “Clinician will respond within 2 hours”; the storyboard calls it a “Care Coordinator Message Center.” The staffing model is not established. [DOC architecture.md §10.7] [LIVE GLP-1 article]
  13. Whether the patient can choose the Zepbound presentation. The PDP lets the patient select KwikPen / auto-injector / vial and routes to that medication_option_sku_id; whether the prescriber honors it is unknown. This is the difference between $299 and $1,074 cash. [CODE components/ProductDetailPage/RequestPrescriptionCta.tsx:18-48] [LIVE cash prices]
  14. Needle supply. KwikPen requires a separate pen-needle purchase; GM sells no needle SKU (only a visit for diabetes supplies, 300467). Whether the pharmacy/care team tells the patient is unknown. [PUBLIC LillyDirect] [LIVE 300467]
  15. Which professional corporation furnishes the DTC GLP-1 visit. The telehealth consent names Emerald/Centennial/Ruby; the separate “Vital Informed Consent” names OpenLoop/Reliant.MD/MECNB. Which consent is shown for which path is not established. [LIVE both pages]
  16. After-hours clinical escalation. No nurse line, on-call clinician pager, or symptom-triage engine was observed; the only emergency instruction is 911. [LIVE consent] [CODE negative]
  17. Refill reminder offset and channel. earliest_fill_date is the gate; the reminder may be email, SMS, in-app, or none. [CODE] [LIVE consent]
  18. Whether the week-4 follow-up is free/included. The public model is fee-for-visit; no subscription/bundled follow-up was observed. [LIVE Lilly page “No subscription needed”]
  19. Check-in dismissal semantics. snooze and dismiss remove the card; whether the underlying criteria remain pending (and therefore block renewal) is not visible client-side. [CODE nextStepCardsApi]
  20. Adherence measurement. GM has no dose log; whether it buys fill data from a pharmacy/PBM switch or infers from its own orders is unknown. [CODE negative] [INFERENCE]

7. Handoff to other evidence files

  • Cross-reference to evidence A (acquisition): the SEO→visit path and the $25/$30/$100 price ladder are shared; E confirms the post-visit price presentation and the $299/$399/$449 drug ladder. Do not attribute the $25 to the drug.
  • Cross-reference to evidence C (intake): E1 depends on the GLP-1 evaluation’s screening/history questionnaires (300543 UUIDs 11340c6b…, 3cdcfa37…). The check-in questionnaire is a separate renewal-criteria questionnaire, excluded server-side from dashboard/show [CODE lib/store/api/dashboardApi.ts:14].
  • Cross-reference to evidence D (checkout/labs): E1.1–E1.4 uses the same PharmacyOrder and Stripe path D maps; E adds the refill and new-strength re-entry, and the 28-day/45-day timing. The gm_card BIN/PCN/group/member is the delegation path.
  • Cross-reference to evidence F (backoffice): E7/E9 are F13/F14 from the patient side. F’s F11 state chain created → pharmacy_selected → order_placed → dispensed is not supported by the recovered client contract: the client exposes state plus cancel/switch flags and no dispense/ack feed; whether a server-side dispense feed exists is Unknown [CODE lib/store/api/pharmacyOrderApi.ts:15-24]. F13’s “checklist gates refills on questionnaire + labs + visit” should be qualified: the model supports those types, but the GLP-1 criteria set is server-side and unobserved.
  • Handoff to Main (tech plan): the highest-leverage missing integrations are (1) a pharmacy dispense/ack feed, (2) a dose/adherence event, (3) a weight/vitals capture or device sync, (4) a PA status webhook, and (5) an after-hours symptom-triage path. None exists in the recovered client.
  • Handoff to Main (operating plan): staff the fulfillment queue (pharmacy transmission failures, PA, out-of-stock) at least as heavily as the clinical review queue; the 1★ tail is fulfillment, not diagnosis [DOC adversarial-and-market-report.md §3.6].